PIPERIDINE DERIVATIVE, PIPERAZINE DERIVATIVE AND AGENT FOR TREATMENT OF DISEASE INVOLVING CENTRAL NERVOUS SYSTEM DISORDERS
申请人:Mita Shiro
公开号:US20110263862A1
公开(公告)日:2011-10-27
A novel piperidine derivative and a novel piperazine derivative which are useful as novel sigma receptor ligands, and an agent for treatment of diseases involving a central nervous system disorders, said agent containing one of the compound as an active ingredient. The agent contains a compound represented by general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient:
wherein X represents an alkylene group having 1 to 5 carbon atoms, and the alkylene group may be substituted by one or more alkyl groups each having 1 to 2 carbon atoms; Y represents a carbon atom or a nitrogen atom; and R1 and R2 each independently represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 2 carbon atoms or an alkoxy group having 1 to 2 carbon atoms.
一种新型哌啶衍生物和一种新型哌嗪衍生物,可用作新型σ受体配体,以及一种用于治疗涉及中枢神经系统疾病的药剂,该药剂含有其中一种化合物作为活性成分。该药剂含有以下通式(I)所表示的化合物或其药学上可接受的盐作为活性成分:其中,X代表具有1至5个碳原子的烷基,该烷基可以被一个或多个具有1至2个碳原子的烷基取代;Y代表碳原子或氮原子;R1和R2各自独立地代表氢原子、卤素原子、具有1至2个碳原子的烷基或具有1至2个碳原子的烷氧基。